Skip to main content
Signal8

Machatha Stephen

SEC insider (Form 3/4/5 filer). CIK 0001836354. Chief Development Officer at Aldeyra Therapeutics, Inc. (ALDX). 2 reported Form 4/5 transactions since Sep 2024; latest on Aug 11, 2025. Located in LEXINGTON, MA.

Companies Machatha Stephen has filed insider reports for

  • Aldeyra Therapeutics, Inc. (ALDX): Officer, Chief Development Officer
Machatha Stephen profile photo

Machatha Stephen

CIK: 0001836354

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Aldeyra Therapeutics, Inc. logo
ALDX

Aldeyra Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Aldeyra Therapeutics, Inc. logo
    ALDX

    Aldeyra Therapeutics, Inc.

    Aug 11, 2025
    Sale
    Direct
    22.1K shares at avg. $5.15$114K
  • Aldeyra Therapeutics, Inc. logo
    ALDX

    Aldeyra Therapeutics, Inc.

    Mar 4, 2025
    Award

    Stock Option (right to buy)

    Direct
    202.4K shares-

1-2 of 2